Ever Neuro Pharma may build production plant for Cerebrolysin in Russia

Austrian pharmaceutical producer Ever Neuro Pharma is considering building a plant for the production and packaging of its flagship drug Cerebrolysin, a peptide preparation with neurotropic activity, in the Russian city St Petersburg. Cerebrolysin is a recognized IV treatment for stroke, dementia and brain injuries.

According to Sergei Derevyannyh, head of Ever Neuro Pharma Russia, the company already produces and packages Cerebrolysin in Russia at the facility of Biocom plant (in the Stavropol region), but plans to expand its local capacities through the launch of a new plant in St Petersburg.

The establishment of the new plant could be beneficial for Ever Neuro Pharma in terms of logistics and further business development in Russia, taking into account the good economic and geographical location of St Petersburg. The amount of investments in the project has not yet been disclosed.